| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Simone Sacco, Akash Virupakshaiah, Nico Papinutto, Vinicius A Schoeps, Amit Akula, Haojun Zhao, Jennifer Arona, William A Stern, Janet Chong, Janace Hart, Scott S Zamvil, Pascal Sati, Roland G Henry, Emmanuelle Wauban. Susceptibility-based imaging aids accurate distinction of pediatric-onset MS from myelin oligodendrocyte glycoprotein antibody-associated disease. Multiple sclerosis (Houndmills, Basingstoke, England). 2023-10-28. PMID:37897254. |
myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad) and pediatric-onset multiple sclerosis (poms) share clinical and magnetic resonance imaging (mri) features but differ in prognosis and management. |
2023-10-28 |
2023-11-08 |
Not clear |
| Yufei Wang, Qusang Danzeng, Wencan Jiang, Bingqing Han, Xiaowen Zhu, Ziwei Liu, Jialu Sun, Kelin Chen, Guojun Zhan. A retrospective study of myelin oligodendrocyte glycoprotein antibody-associated disease from a clinical laboratory perspective. Frontiers in neurology. vol 14. 2023-09-29. PMID:37771453. |
to analyze the differences in laboratory data between patients with myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad), multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (nmosd). |
2023-09-29 |
2023-10-07 |
Not clear |
| Benjamin Vlad, Ina Reichen, Stephan Neidhart, Marc Hilty, Dimitra Lekaditi, Christine Heuer, Amanda Eisele, Mario Ziegler, Markus Reindl, Andreas Lutterotti, Axel Regeniter, Ilijas Jelci. Basic CSF parameters and MRZ reaction help in differentiating MOG antibody-associated autoimmune disease versus multiple sclerosis. Frontiers in immunology. vol 14. 2023-09-25. PMID:37744325. |
basic csf parameters and mrz reaction help in differentiating mog antibody-associated autoimmune disease versus multiple sclerosis. |
2023-09-25 |
2023-10-07 |
Not clear |
| Javier Villacieros-\\xc3\\x81lvarez, Carmen Espejo, Georgina Arrambide, Mireia Castillo, Pere Carbonell-Mirabent, Marta Rodriguez, Luca Bollo, Joaqu\\xc3\\xadn Castill\\xc3\\xb3, Manuel Comabella, Ingrid Gal\\xc3\\xa1n, Luciana Midaglia, Neus Mongay, Carlos Nos, Jordi Rio, Breogan Rodr\\xc3\\xadguez-Acevedo, Jaume Sastre-Garriga, Carmen Tur, Angela Vidal-Jordana, Andreu Vilaseca, Ana Zabalza, Cristina Auger, Alex Rovira, Xavier Montalban, Mar Tintor\\xc3\\xa9, \\xc3\\x81lvaro Cobo-Calv. MOG antibodies in adults with a first demyelinating event suggestive of multiple sclerosis. Annals of neurology. 2023-09-14. PMID:37705507. |
mog antibodies in adults with a first demyelinating event suggestive of multiple sclerosis. |
2023-09-14 |
2023-10-07 |
Not clear |
| Javier Villacieros-\\xc3\\x81lvarez, Carmen Espejo, Georgina Arrambide, Mireia Castillo, Pere Carbonell-Mirabent, Marta Rodriguez, Luca Bollo, Joaqu\\xc3\\xadn Castill\\xc3\\xb3, Manuel Comabella, Ingrid Gal\\xc3\\xa1n, Luciana Midaglia, Neus Mongay, Carlos Nos, Jordi Rio, Breogan Rodr\\xc3\\xadguez-Acevedo, Jaume Sastre-Garriga, Carmen Tur, Angela Vidal-Jordana, Andreu Vilaseca, Ana Zabalza, Cristina Auger, Alex Rovira, Xavier Montalban, Mar Tintor\\xc3\\xa9, \\xc3\\x81lvaro Cobo-Calv. MOG antibodies in adults with a first demyelinating event suggestive of multiple sclerosis. Annals of neurology. 2023-09-14. PMID:37705507. |
mog antibodies (mog-ab) distinguish multiple sclerosis (ms) from mog-associated disease (mogad) in most cases. |
2023-09-14 |
2023-10-07 |
Not clear |
| Charlotta Hansson, Cristina Lebrero-Fern\\xc3\\xa1ndez, Karin Sch\\xc3\\xb6n, Davide Angeletti, Nils Lyck. Tr1 cell-mediated protection against autoimmune disease by intranasal administration of a fusion protein targeting cDC1 cells. Mucosal immunology. vol 16. issue 4. 2023-08-11. PMID:37192682. |
the cta1 r7k mutant - myelin oligodendrocyte glycoprotein (mog), or proteolipid protein (plp) - dd (cta1r7k-mog/plp-dd) fusion proteins effectively reduced clinical symptoms in the experimental autoimmune encephalitis model of multiple sclerosis. |
2023-08-11 |
2023-08-16 |
Not clear |
| D D Eliseeva, A K Kalashnikova, V V Bryukhov, N A Andreeva, N V Zhorzholadze, Yu K Murakhovskaya, T D Krilova, P G Tsygankova, M N Zakharova, N L Shereme. [Hereditary optic neuropathy associated with demyelinating diseases of the central nervous system]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. vol 123. issue 7. Vyp. 2. 2023-08-10. PMID:37560844. |
optic neuritis can occur at the onset or be one of the syndromes within multiple sclerosis (ms), neuromyelitis optica spectrum disorders (nmosd), and myelin oligodendrocyte glycoprotein (mog) antibody disease (mogad). |
2023-08-10 |
2023-08-16 |
Not clear |
| Yoav Shulman, Lena Finkelstein, Yakir Levi, Dimitry Kovalchuk, Ayelet Weksler, Alejandro Reichstein, Keren Kigel-Zur, Mazal Davidi, Isaac Levi, Avital Schauder, Keren Rubin, Elhanan Achituv, David Castel, Sigal Meili. A novel sensory wave (P25) in MOG-induced EAE murine model. The journal of pain. 2023-07-31. PMID:37524220. |
myelin oligodendrocyte glycoprotein (mog)-induced experimental autoimmune encephalomyelitis (eae) is a murine model for multiple sclerosis (ms). |
2023-07-31 |
2023-08-14 |
mouse |
| Christopher J Bridgeman, Shrey A Shah, Robert S Oakes, Christopher M Jewel. Dissecting regulatory T cell expansion using polymer microparticles presenting defined ratios of self-antigen and regulatory cues. Frontiers in bioengineering and biotechnology. vol 11. 2023-07-13. PMID:37441198. |
using rapamycin (rapa) as a modulatory cue and myelin self-peptide (myelin oligodendrocyte glycoprotein- mog) - self-antigen attacked during multiple sclerosis (ms), we integrate these components into polymer particles over a range of ratios and concentrations without altering the physicochemical properties of the particles. |
2023-07-13 |
2023-08-14 |
Not clear |
| Qiao Xu, Xixi Yang, Zhandong Qiu, Dawei Li, Hongxing Wang, Hong Ye, Lidong Jiao, Jing Zhang, Li Di, Peng Lei, Huiqing Dong, Zheng Li. Clinical features of MOGAD with brainstem involvement in the initial attack versus NMOSD and MS. Multiple sclerosis and related disorders. vol 77. 2023-07-04. PMID:37402345. |
clinical features of mogad with brainstem involvement in the initial attack versus nmosd and ms. to assess the characteristics of myelin oligodendrocyte glycoprotein (mog) antibody-associated disorder (mogad) with brainstem involvement in the first event (bsife) and make comparisons with aquaporin-4-igg seropositive neuromyelitis optica spectrum disorder (aqp4-igg-nmosd) and multiple sclerosis (ms). |
2023-07-04 |
2023-08-14 |
Not clear |
| Vyanka Redenbaugh, Nicholas H Chia, Laura Cacciaguerra, Jennifer A McCombe, Jan-Mendelt Tillema, John J Chen, A Sebastian Lopez Chiriboga, Elia Sechi, Yael Hacohen, Sean J Pittock, Eoin P Flanaga. Comparison of MRI T2-lesion evolution in pediatric MOGAD, NMOSD, and MS. Multiple sclerosis (Houndmills, Basingstoke, England). 2023-05-23. PMID:37218499. |
magnetic resonance imaging (mri) t2-lesions resolve more often in myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad) than aquaporin-4 igg-positive neuromyelitis optica spectrum disorder (aqp4 + nmosd) and multiple sclerosis (ms) in adults but few studies analyzed children. |
2023-05-23 |
2023-08-14 |
Not clear |
| Paul Elsbernd, Laura Cacciaguerra, Karl N Krecke, John J Chen, David Gritsch, A Sebastian Lopez-Chiriboga, Elia Sechi, Vyanka Redenbaugh, Padraig P Morris, Jonathan L Carter, Dean M Wingerchuk, Jan-Mendelt Tillema, Cristina Valencia-Sanchez, Smathorn Thakolwiboon, Sean J Pittock, Eoin P Flanaga. Cerebral enhancement in MOG antibody-associated disease. Journal of neurology, neurosurgery, and psychiatry. 2023-05-23. PMID:37221051. |
limited data exist on brain mri enhancement in myelin-oligodendrocyte-glycoprotein (mog) antibody-associated disease (mogad) and differences from aquaporin-4-igg-positive-neuromyelitis-optica-spectrum-disorder (aqp4+nmosd), and multiple sclerosis (ms). |
2023-05-23 |
2023-08-14 |
Not clear |
| Kiandokht Keyhanian, Bart K Chwalis. The Treatment of Acute Optic Neuritis. Seminars in ophthalmology. 2023-05-10. PMID:37162276. |
despite the high incidence of optic neuritis (on), and the growing number of therapeutic options for the long-term treatment of diseases associated with on including multiple sclerosis (ms), neuromyelitis optica spectrum disorder (nmosd) and mog antibody associated disease (mogad), there are still only limited therapeutic options for treating an acute event of optic neuritis. |
2023-05-10 |
2023-08-14 |
Not clear |
| Brian Florenzo, J Nicholas Brento. Socioeconomic, Clinical, and Laboratory Parameters Differentiating Pediatric Patients With MOG Antibody-Associated Disease and Multiple Sclerosis. Journal of child neurology. 2023-05-01. PMID:37122175. |
socioeconomic, clinical, and laboratory parameters differentiating pediatric patients with mog antibody-associated disease and multiple sclerosis. |
2023-05-01 |
2023-08-14 |
human |
| Simone Mader, Samantha Ho, Hoi Kiu Wong, Selia Baier, Stephan Winklmeier, Carolina Riemer, Heike R\\xc3\\xbcbsamen, Iris Marti Fernandez, Ramona Gerhards, Cuilian Du, Omar Chuquisana, Jan D L\\xc3\\xbcnemann, Anja Lux, Falk Nimmerjahn, Monika Bradl, Naoto Kawakami, Edgar Mein. Dissection of complement and Fc-receptor-mediated pathomechanisms of autoantibodies to myelin oligodendrocyte glycoprotein. Proceedings of the National Academy of Sciences of the United States of America. vol 120. issue 13. 2023-03-21. PMID:36943883. |
autoantibodies against myelin oligodendrocyte glycoprotein (mog) have recently been established to define a new disease entity, mog-antibody-associated disease (mogad), which is clinically overlapping with multiple sclerosis. |
2023-03-21 |
2023-08-14 |
human |
| Osman Corbali, Tanuja Chitni. Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease. Frontiers in neurology. vol 14. 2023-03-17. PMID:36925938. |
interestingly, pediatric mogad is not more aggressive than adult-onset mogad, unlike in multiple sclerosis (ms), where annualized relapse rates are three times higher in pediatric-onset ms. mogad pathophysiology is driven by acute attacks during which t cells and mog antibodies cross blood brain barrier (bbb). |
2023-03-17 |
2023-08-14 |
Not clear |
| Susanna Asseyer, Nasrin Asgari, Jeffrey Bennett, Omer Bialer, Yolanda Blanco, Francesca Bosello, Anna Camos-Carreras, Edgar Carnero Contentti, Sara Carta, John Chen, Claudia Chien, Mashina Chomba, Russell C Dale, Josep Dalmau, Kristina Feldmann, Eoin P Flanagan, Caroline Froment Tilikete, Carolina Garcia-Alfonso, Joachim Havla, Mark Hellmann, Ho Jin Kim, Philipp Klyscz, Frank Konietschke, Chiara La Morgia, Marco Lana-Peixoto, Maria Isabel Leite, Netta Levin, Michael Levy, Sara Llufriu, Pablo Lopez, Itay Lotan, Alessandra Lugaresi, Romain Marignier, Sara Mariotto, Susan P Mollan, Cassandra Ocampo, Frederike Cosima Oertel, Maja Olszewska, Jacqueline Palace, Lekha Pandit, Jos\\xc3\\xa9 Luis Peralta Uribe, Sean Pittock, Sudarshini Ramanathan, Natthapon Rattanathamsakul, Albert Saiz, Sara Samadzadeh, Bernardo Sanchez-Dalmau, Deanna Saylor, Michael Scheel, Tanja Schmitz-H\\xc3\\xbcbsch, Jemal Shifa, Sasitorn Siritho, Pia S Sperber, Prem S Subramanian, Alon Tiosano, Adi Vaknin-Dembinsky, Alvaro Jose Mejia Vergara, Adi Wilf-Yarkoni, Luis Alfonso Zarco, Hanna G Zimmermann, Friedemann Paul, Hadas Stiebel-Kalis. The Acute Optic Neuritis Network (ACON): Study protocol of a non-interventional prospective multicenter study on diagnosis and treatment of acute optic neuritis. Frontiers in neurology. vol 14. 2023-03-13. PMID:36908609. |
optic neuritis (on) often occurs at the presentation of multiple sclerosis (ms), neuromyelitis optica spectrum disorders (nmosd), and myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad). |
2023-03-13 |
2023-08-14 |
Not clear |
| W Doelman, R C Reijnen, N Dijksman, A P A Janssen, N van Driel, B A 't Hart, I Philippens, C Araman, W Baron, S I van Kastere. Citrullinated human and murine MOG The Journal of biological chemistry. 2023-02-25. PMID:36841486. |
citrullinated human and murine mog the peptide spanning residues 35-55 of the protein myelin oligodendrocyte glycoprotein (mog) has been studied extensively in its role as a key autoantigen in the neuroinflammatory autoimmune disease multiple sclerosis (ms). |
2023-02-25 |
2023-08-14 |
human |
| Andrey E Urusov, Anna S Tolmacheva, Kseniya S Aulova, Georgy A Nevinsk. Autoantibody-Abzymes with Catalase Activity in Experimental Autoimmune Encephalomyelitis Mice. Molecules (Basel, Switzerland). vol 28. issue 3. 2023-02-11. PMID:36770997. |
at the same time, the development in c57bl/6 mice of experimental autoimmune encephalomyelitis (eae, simulating human multiple sclerosis) happens as a result of the violation of bone marrow hematopoietic stem cell differentiation profiles integrated with the production of toxic auto-antibodies splitting the basic myelin protein, myelin oligodendrocyte glycoprotein (mog), histones, and dna. |
2023-02-11 |
2023-08-14 |
mouse |
| Brenda Banwell, Jeffrey L Bennett, Romain Marignier, Ho Jin Kim, Fabienne Brilot, Eoin P Flanagan, Sudarshini Ramanathan, Patrick Waters, Silvia Tenembaum, Jennifer S Graves, Tanuja Chitnis, Alexander U Brandt, Cheryl Hemingway, Rinze Neuteboom, Lekha Pandit, Markus Reindl, Albert Saiz, Douglas Kazutoshi Sato, Kevin Rostasy, Friedemann Paul, Sean J Pittock, Kazuo Fujihara, Jacqueline Palac. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. The Lancet. Neurology. 2023-01-27. PMID:36706773. |
serum antibodies directed against myelin oligodendrocyte glycoprotein (mog) are found in patients with acquired cns demyelinating syndromes that are distinct from multiple sclerosis and aquaporin-4-seropositive neuromyelitis optica spectrum disorder. |
2023-01-27 |
2023-08-14 |
Not clear |